Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
      Google Scholar   
Citation:
Cancer vol 110 (3) 670-7
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA-21115, CA-25224, CA-32102, CA-35101, CA-35195, CA-37404, CA-38926  
Corr. Author:
 
Authors:
                         
Primary Study
NCCTG-9741
Secondary Studies:
Phases:
3
Keywords:
Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Colorectal Neoplasms, Disease Progression, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Organoplatinum Compounds, Survival Rate, Treatment Outcome